{
  "resourceType": "ResearchStudy",
  "extension": [
    null
  ],
  "identifier": [
    {
      "type": {
        "text": "Clinical Study Sponsor"
      },
      "system": "https://example.org/sponsor-identifier",
      "value": "H2Q-MC-LZZT"
    },
    {
      "type": {
        "text": "Study Registry"
      },
      "system": "https://example.org/sponsor-identifier",
      "value": "NCT12345678"
    },
    {
      "type": {
        "text": "Amendment Identifier"
      },
      "system": "https://example.org/amendment-identifier",
      "value": ""
    }
  ],
  "version": "2",
  "title": "Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimer's Disease",
  "label": [
    {
      "type": {
        "coding": [
          {
            "system": "http://www.cdisc.org",
            "version": "2023-12-15",
            "code": "C94108",
            "display": "Study Acronym"
          }
        ]
      },
      "value": "LZZT"
    },
    {
      "type": {
        "coding": [
          {
            "system": "http://www.cdisc.org",
            "version": "2023-12-15",
            "code": "C99905x1",
            "display": "Brief Study Title"
          }
        ]
      },
      "value": "Xanomeline (LY246708)"
    }
  ],
  "date": "2006-06-01",
  "status": "draft",
  "phase": {
    "coding": [
      {
        "system": "http://www.cdisc.org",
        "version": "2023-12-15",
        "code": "C15601",
        "display": "Phase II Trial"
      }
    ],
    "text": "Phase II Trial"
  },
  "associatedParty": [
    null,
    null,
    null
  ],
  "progressStatus": [
    null
  ]
}